Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

All studies

Sacituzumab Tirumotecan (sac-TMT)

STRAP

National Cancer Centre Singapore · Phase 2 · Not yet recruiting · Enrollment 68

NCT07521670

Catalyst Primary completion. 10.31.2028. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.

ArmReported safety

A count stays a count. This page does not turn a count into a percent.